BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18610723)

  • 1. [Inflammation and auto-immunity: an update on the NOD-like receptors and their clinical role].
    Gaide O
    Rev Med Suisse; 2008 Apr; 4(155):1103-6. PubMed ID: 18610723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular regulation of inflammation and cell death.
    Yeretssian G; Labbé K; Saleh M
    Cytokine; 2008 Sep; 43(3):380-90. PubMed ID: 18703350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nod-like proteins in inflammation and disease.
    Carneiro LA; Magalhaes JG; Tattoli I; Philpott DJ; Travassos LH
    J Pathol; 2008 Jan; 214(2):136-48. PubMed ID: 18161746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections.
    Opitz B; Eitel J; Meixenberger K; Suttorp N
    Thromb Haemost; 2009 Dec; 102(6):1103-9. PubMed ID: 19967140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nod-like proteins in immunity, inflammation and disease.
    Fritz JH; Ferrero RL; Philpott DJ; Girardin SE
    Nat Immunol; 2006 Dec; 7(12):1250-7. PubMed ID: 17110941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction pathways used by NLR-type innate immune receptors.
    Kufer TA
    Mol Biosyst; 2008 May; 4(5):380-6. PubMed ID: 18414735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate recognition of intracellular pathogens: detection and activation of the first line of defense.
    Rasmussen SB; Reinert LS; Paludan SR
    APMIS; 2009 May; 117(5-6):323-37. PubMed ID: 19400860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sunburned skin activates inflammasomes.
    Faustin B; Reed JC
    Trends Cell Biol; 2008 Jan; 18(1):4-8. PubMed ID: 18083030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular pattern-recognition receptors.
    Dostert C; Meylan E; Tschopp J
    Adv Drug Deliv Rev; 2008 Apr; 60(7):830-40. PubMed ID: 18280002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases.
    McDermott MF; Tschopp J
    Trends Mol Med; 2007 Sep; 13(9):381-8. PubMed ID: 17822957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases.
    Schaefer L
    Curr Opin Pharmacol; 2010 Apr; 10(2):185-90. PubMed ID: 20045380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Danger signals and inflammasomes in autoinflammatory and autoimmune diseases].
    Bendtzen K
    Ugeskr Laeger; 2011 Sep; 173(38):2340-3. PubMed ID: 21936977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family.
    Ye Z; Ting JP
    Curr Opin Immunol; 2008 Feb; 20(1):3-9. PubMed ID: 18280719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity.
    Erdman LK; Finney CA; Liles WC; Kain KC
    Mol Biochem Parasitol; 2008 Dec; 162(2):105-11. PubMed ID: 18804125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of altered microbial signaling via mutant NODs in intestinal inflammation.
    Rescigno M; Nieuwenhuis EE
    Curr Opin Gastroenterol; 2007 Jan; 23(1):21-6. PubMed ID: 17133080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Innate immunity, autoimmunity and autoinflammation].
    Bendtzen K
    Ugeskr Laeger; 2011 Sep; 173(38):2337-40. PubMed ID: 21936976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation.
    Peyrin-Biroulet L; Vignal C; Dessein R; Simonet M; Desreumaux P; Chamaillard M
    Trends Microbiol; 2006 Oct; 14(10):432-8. PubMed ID: 16942880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.